Company Tellgen Corporation

Equities

300642

CNE100002P42

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
14.39 ^CNY	+0.21%		+4.81%	-18.47%

22/04	Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04	Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.	CI

Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.

Number of employees: 574

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnostic Reagents 92.2 %	534	74.5 %	500	92.2 %	-6.23%
In Vitro Diagnostic Instruments 7.0 %	178	24.9 %	38	7.0 %	-78.75%
Service 0.8 %	4	0.5 %	4	0.8 %	+17.29%
Other 0.0 %	0	0.0 %	0	0.0 %	-63.95%

CNY in Million	2022	Weight	2023	Weight	Delta
China 98.8 %	704	98.3 %	536	98.8 %	-23.83%
Abroad 1.2 %	12	1.7 %	6	1.2 %	-45.46%

Managers	Title	Age	Since
Jian Er Yao CEO	Chief Executive Officer	54	06/03/06
Xiao Qing Wang BRD	Director/Board Member	45	01/09/01
En Huan Yang BRD	Director/Board Member	42	01/09/01

Members of the board	Title	Age	Since
Jian Er Yao CEO	Chief Executive Officer	54	06/03/06
Zhang Fu Yu BRD	Director/Board Member	61	14/19/14
En Huan Yang BRD	Director/Board Member	42	01/09/01
Xiao Qing Wang BRD	Director/Board Member	45	01/09/01
Wei Yu BRD	Director/Board Member	71	09/20/09
Jia Xiang Zhao BRD	Director/Board Member	48	09/20/09
Xiao Feng Zhang CHM	Chairman	45	09/20/09
Hong Zhan BRD	Director/Board Member	56	09/20/09
Shao Xiong Chen BRD	Director/Board Member	63	25/12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	167,275,083	108,294,626 ( 64.74 %)	3,148,842 ( 1.882 %)	64.74 %

Name	Equities	%	Valuation
Zhang Fu Yu 8.740 %	12,035,800	8.740 %	23 M ¥
Zhong Ou Asset Management Co., Ltd 1.714 %	2,359,907	1.714 %	5 M ¥
TELLGEN CORPORATION 0.7531 %	1,037,040	0.7531 %	2 M ¥
China Southern Asset Management Co., Ltd. 0.6741 %	928,260	0.6741 %	2 M ¥
Maxwealth Fund Management Co., Ltd. 0.2768 %	381,220	0.2768 %	739 502 ¥
Gfund Management Co., Ltd. 0.1340 %	184,500	0.1340 %	357 899 ¥
Bosera Asset Management Co., Ltd. 0.1175 %	161,746	0.1175 %	313 760 ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 0.0994 %	136,880	0.0994 %	265 524 ¥
HSBC Jintrust Fund Management Co. Ltd. 0.0671 %	92,400	0.0671 %	179 240 ¥
China Asset Management Co., Ltd. 0.0322 %	44,300	0.0322 %	85 934 ¥

Name	Equities	%	Valuation
TELLGEN CORPORATION 0.75%	1,037,040	0.75%	2,011,681 $

Tellgen Corp.

Building 1, 115 Bibo Road Lane 572, Pilot Free Trade Zone

201203, Shanghai

+86 21 5027 3499

http://www.tellgen.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
TELLGEN CORPORATION	-18.47%	324M
BIOMÉRIEUX	-1.89%	12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.68B
DIASORIN S.P.A.	-1.31%	5.29B
LANTHEUS HOLDINGS, INC.	+21.82%	5.18B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-50.89%	3.29B
ANDON HEALTH CO., LTD.	+6.42%	2.6B
VITROLIFE AB	-10.02%	2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B

Diagnostic & Testing Substances